Dr. Stuart W. Peltz is a seasoned leader in the biotechnology industry, having co-founded PTC Therapeutics, Inc. and serving as its CEO since its inception in 1998 until March 2023. He holds a Ph.D. in Molecular Biology from the University...
Dr. Stuart W. Peltz is a seasoned leader in the biotechnology industry, having co-founded PTC Therapeutics, Inc. and serving as its CEO since its inception in 1998 until March 2023. He holds a Ph.D. in Molecular Biology from the University of Pennsylvania and is recognized for his expertise in RNA biology. Under his leadership, PTC Therapeutics has focused on developing cutting-edge therapies for rare genetic diseases and has made notable advancements in the biotech field. Dr. Peltz retired in early 2023, but he continues to contribute to the company as a Senior Advisor and member of the Scientific Advisory Board. His health expertise and management experience led PTC to achieve significant successes and build a strong reputation within the industry. In 2023, his total compensation reached about $5.7 million, which involved a salary, stock options, and other benefits, reflecting his substantial contributions and value to the company. Throughout his career, Dr. Peltz has also received accolades, including being named in PharmaVoice's 100 Most Inspiring People. His work has helped shape modern biopharmaceutical innovation, making him a key figure in the landscape of biotechnology.